Skip to content Skip to footer
Menu Close
Close

Neurology

Enroll in Tardive Dyskinesia Clinical Trials Focused on Improving Control Over Involuntary Movements

Tardive Dyskinesia Research Studies

Tardive Dyskinesia Clinical Trials in Los Angeles

Uncontrollable movements of the face, tongue, arms, or other parts of the body can make everyday interactions feel frustrating and unpredictable. For individuals living with tardive dyskinesia (TD), these symptoms can impact confidence, communication, and overall quality of life.

Zillan Clinical Research is conducting Phase II tardive dyskinesia clinical trials evaluating the safety, effectiveness, and tolerability of an investigational study drug in adults with moderate to severe TD. Eligible participants with conditions such as schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder associated with neuroleptic-induced TD may receive study-related assessments, monitoring, and clinical care throughout the study without any charges.

Check Eligibility
About This Study

Exploring New Possibilities for Living with Tardive Dyskinesia

Living with persistent involuntary movements can be physically and emotionally challenging, especially when symptoms continue despite available management strategies. While ongoing clinical trials for involuntary movements continue to advance neurological care, there is still a need for additional treatment approaches that may provide meaningful improvement for people affected by TD.

The current tardive dyskinesia clinical trials at Zillan Clinical Research are part of a randomized, double-blind, placebo-controlled Phase II study evaluating how well the study drug may reduce the severity of abnormal movements in adults with moderate to severe TD. Researchers will assess changes in movement severity using standardized clinical rating scales while closely monitoring participant safety and tolerability throughout the study.

Now Enrolling

Current Status

Tardive Dyskinesia (TD)

Condition

Phase II

Phase

Partner With Us
Our Values

Why Patients Trust Us

At Zillan Clinical Research, we understand that participating in TD drug research is more than joining a study. It is an opportunity to contribute to future treatment discoveries while receiving attentive care from a dedicated research team.

Integrity

Conducting every study with transparency, respect, and a strong commitment to ethical research practices.

Patient Safety

Providing thorough health evaluations and continuous monitoring throughout each stage of participation.

Scientific Excellence

Following rigorous research methods to ensure accurate, reliable, and meaningful study outcomes.

Innovation

Supporting the development of new therapies that may transform future care for neurological conditions.

Participant-Focused Experience

Creating a supportive environment where participants feel informed, valued, and comfortable throughout their journey.

Trusted Clinical Standards

Following ICH, GCP, and regulatory guidelines to protect participant rights, safety, and well-being.

FAQ

Frequently Asked Questions

Tardive dyskinesia clinical trials are research studies that evaluate investigational therapies to determine whether they are safe and effective in reducing involuntary movements associated with TD.

This study is evaluating an investigational treatment compared with a placebo to determine its effectiveness, safety, and tolerability in improving symptoms of moderate to severe tardive dyskinesia.

Adults diagnosed with neuroleptic-induced tardive dyskinesia for at least three months, along with a diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder, may be eligible based on additional study criteria and clinical assessments.

Participants will attend scheduled visits where they undergo movement evaluations, health assessments, and ongoing safety monitoring while researchers assess the impact of the study treatment.

The goal of this study is to determine whether the investigational study drug can safely reduce the severity of abnormal involuntary movements compared with a placebo.

Yes, Zillan Clinical Research conducts tardive dyskinesia clinical trials in Los Angeles focused on advancing potential treatment options for individuals living with TD.

All studies are conducted under strict ethical and clinical research standards. Participants receive close medical oversight, regular evaluations, and ongoing safety monitoring throughout the trial.

Still have questions? Our team is here to support you with your clinical research needs.
Contact Our Team

Join Us

Supporting Innovation
Through Structured Clinical Trials

Join studies designed to advance medical knowledge and support the development of next-generation therapies.
Take the First Step Today